An amyloid-informed multimodal brain age gap (BAG) model captures convergent AD-related pathology, biomarker alterations, and cognitive vulnerability beyond amyloid burden alone, supporting its value for individualized risk stratification and prevention-focused assessment.
Key Findings
Results
Higher BAG was associated with greater odds of cognitive impairment across the AD continuum, with stronger effects in amyloid-positive individuals.
The cohort included 990 community-dwelling adults spanning normal cognition, subjective cognitive decline (SCD), mild cognitive impairment (MCI), and dementia.
Participants were recruited from the Chinese Preclinical Alzheimer's Disease Study (CPAS) from community settings and memory clinics.
Effects of BAG on cognitive status classification were stronger in Aβ-positive individuals compared to the overall cohort.
Cross-sectional analysis using integrated machine-learning models was used to derive BAG estimates.
Results
BAG explained more cognitive variance than global amyloid-β burden and was linked to multidomain cognitive deficits.
Regional Aβ-PET and structural MRI were both used to inform BAG estimation in the multimodal model.
The multimodal BAG model outperformed global Aβ burden alone in explaining variance in cognitive test performance.
Elevated BAG corresponded to adverse plasma biomarker profiles indicative of early Alzheimer's-related pathology.
Higher BAG was associated with higher p-tau217, p-tau181, neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) levels.
Higher BAG was also associated with lower Aβ42/40 ratio in plasma.
These associations indicate that elevated BAG corresponds to early biomarker alterations across the AD continuum.
Plasma biomarkers assessed included p-tau217, p-tau181, NfL, GFAP, and Aβ42/40.
Results
Elevated BAG was associated with reduced hippocampus-default mode network (DMN) functional connectivity.
Resting-state fMRI was used to assess hippocampus-DMN connectivity.
Higher BAG corresponded to reduced connectivity between the hippocampus and the default mode network.
This finding links accelerated brain aging as captured by the multimodal BAG to functional network disruption relevant to AD.
Results
Incorporating regional Aβ-PET data alongside structural MRI improved the sensitivity of the BAG model to early AD processes compared to MRI-only models.
MRI-only brain age models were noted to insufficiently reflect Alzheimer's disease pathology.
The multimodal model integrated regional Aβ-PET with structural MRI for BAG estimation.
The amyloid-informed BAG captured convergent AD-related pathology beyond what amyloid burden alone provided.
The model was developed and tested in a sample of 990 community-dwelling adults from the CPAS cohort.
Cui L, Wang Q, Zhang Z, Wang M, Tu Y, Jiang J, et al.. (2026). Spatial amyloid-informed multimodal brain age as an early marker of Alzheimer's-related vulnerability and risk stratification.. The journal of prevention of Alzheimer's disease. https://doi.org/10.1016/j.tjpad.2026.100501